business
What's the Better Dividend Stock Today: AbbVie or Pfizer?
Key takeaways
- PFE ABBV Abb Vie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two top healthcare stocks, and they re investments that can generate a ton of dividend income for your portfolio.
- Abb Vie, which yields 3.2%, has been a dividend growth beast for decades and has been doing a good job of growing its business even after its top-selling drug Humira lost patent protection.
- Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need.
PFE ABBV Abb Vie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two top healthcare stocks, and they re investments that can generate a ton of dividend income for your portfolio.
Abb Vie, which yields 3.2%, has been a dividend growth beast for decades and has been doing a good job of growing its business even after its top-selling drug Humira lost patent protection. It has proven to be a good long-term dividend investment to hang on to.
Will AI create the world s first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue »
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop